Chlamydia pneumoniae -specific serum immune complexes in patients with multiple sclerosis

Abstract

The significance of Chlamydia pneumoniae infection in patients with multiple sclerosis (MS) is unclear. We determined the frequency of serum C. pneumoniae-specific immune complexes in patients with MS, neurological (OND) and healthy controls in a blinded, cross-sectional study. C. pneumoniae immune complexes were detected in 24% (38/156) of MS patients, 16% (11/69) of OND and 15% (77/499) of healthy controls. The odds ratio for all MS patients was 3.95 (95% CI: 2.15 to 7.24; P < 0.0001) accounting for the covariates: sex, age, socio-economic status and area of residence. The odds ratio for recently diagnosed MS patients was 4.33 (95% CI: 1.76 to 10.64; P = 0.001). Systemic C. pneumoniae infection is more frequent in MS patients than the healthy population and occurs early in the course of the disease. Multiple Sclerosis 2007; 14: 292—299. http://msj.sagepub.com

Keywords

Chlamydia pneumoniae immune complexes multiple sclerosis

References

Tsai JC , Gilden DH Chlamydia pneumoniae and multiple sclerosis: no significant association . Trends Microbiol 2001; 9(4): 152-54.

Kaufman M. , Gaydos CA , Sriram S. , Boman J. , Tondella ML , Norton HJ Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results . Mult Scler 2002; 8(4): 289-94.

Chatzipanagiotou S. , Tsakanikas C. , Anagnostouli M. , Rentzos M. , Ioannidis A. , Nicolaou C. Detection of Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis by combination of cell culture and PCR: no evidence for possible association . Mol Diagn 2003; 7(1): 41-43.

Hammerschlag MR , Ke Z. , Lu F. , Roblin P. , Boman J. , Kalman B.

Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis?

J Clin Microbiol 2000; 38(11): 4274-76.

Saiz A. , Marcos MA , Graus F. , Vidal J. , Jimenez de Anta MT No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis . J Neurol 2001; 248(7): 617-18.

Furrows SJ , Hartley JC , Bell J. , Silver N. , Losseff N. , Stevenson S. , et al. Chlamydophila pneumoniae infection of the central nervous system in patients with multiple sclerosis . J Neurol Neurosurg Psychiatry 2004; 75(1): 152-54.

Gieffers J. , Pohl D. , Treib J. , Dittmann R. , Stephan C. , Klotz K. , et al. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis . Ann Neurol 2001; 49(5): 585-89.

Hao Q. , Miyashita N. , Matsui M. , Wang HY , Matsushima T. , Saida T. Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis . Mult Scler 2002; 8(5): 436-40.

Sriram S. , Ljunggren- Rose A. , Yao SY , Whetsell WO, Jr. Detection of chlamydial bodies and antigens in the central nervous system of patients with multiple sclerosis . J Infect Dis 2005; 192(7): 1219-28.

10.

Sriram S. , Stratton CW , Yao S. , Tharp A. , Ding L. , Bannan JD , et al. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis . Ann Neurol 1999; 46(1): 6-14.

11.

Dong-Si T. , Weber J. , Liu YB , Buhmann C. , Bauer H. , Bendl C. , et al. Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis . J Neurol 2004; 251(5): 542-47.

12.

Munger KL , DeLorenze GN , Levin LI , Rubertone MV , Vogelman JH , Peck CA , et al. A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts . Neurology 2004; 62(10): 1799-803.

13.

Munger KL , Peeling RW , Hernan MA , Chasan-Taber L. , Olek MJ , Hankinson SE , et al. Infection with Chlamydia pneumoniae and risk of multiple sclerosis . Epidemiology 2003; 14(2): 141-47.

14.

Stratton CW , Wheldon DB Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae . Trends Microbiol 2006; 14(11): 474-9.

15.

Hogan RJ , Mathews SA , Mukhopadhyay S. , Summersgill JT , Timms P. Chlamydial persistence: beyond the biphasic paradigm . Infect Immun 2004; 72(4): 1843-55.

16.

Rupp J. , Goepel W. , Kramme E. , Jahn J. , Solbach W. , Maass M. CD14 promoter polymorphism -159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes . Genes Immun 2004; 5(5): 435-38.

17.

Stephens RS The cellular paradigm of chlamydial pathogenesis . Trends Microbiol 2003; 11(1): 44-51.

18.

Boman J. , Soderberg S. , Forsberg J. , Birgander LS , Allard A. , Persson K. , et al. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors . J Infect Dis 1998; 178(1): 274-77.

19.

MacIntyre A. , Hammond CJ , Little CS , Appelt DM , Balin BJ Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells . FEMS Microbiol Lett 2002; 217(2): 167-72.

20.

Dreses-Werringloer U. , Gerard HC , Whittum-Hudson JA , Hudson AP Chlamydophila (Chlamydia) pneumoniae infection of Human Astrocytes and Microglia in Culture Displays an Active, Rather than a Persistent, Phenotype . Am J Med Sci 2006; 332(4): 168-174.

21.

Ikejima H. , Friedman H. , Yamamoto Y. Chlamydia pneumoniae infection of microglial cells in vitro: a model of microbial infection for neurological disease . J Med Microbiol 2006; 55(Pt 7): 947-52.

22.

Lenz DC , Lu L. , Conant SB , Wolf NA , Gerard HC , Whittum-Hudson JA , et al. A Chlamydia pneumoniae-specific peptide induces experimental autoimmune encephalomyelitis in rats . J Immunol 2001; 167(3): 1803-8.

23.

Du C. , Yao SY , Ljunggren-Rose A. , Sriram S. Chlamydia pneumoniae infection of the central nervous system worsens experimental allergic encephalitis . J Exp Med 2002; 196(12): 1639-44.

24.

Breithaupt C. , Schubart A. , Zander H. , Skerra A. , Huber R. , Linington C. , et al. Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein . Proc Natl Acad Sci USA 2003; 100(16): 9446-51.

25.

Krametter D. , Niederwieser G. , Berghold A. , Birnbaum G. , Strasser-Fuchs S. , Hartung HP , et al. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker . Mult Scler 2001; 7(1): 13-18.

26.

Derfuss T. , Gurkov R. , Then Bergh F. , Goebels N. , Hartmann M. , Barz C. , et al. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response . Brain 2001; 124(Pt 7): 1325-35.

27.

Dowell SF , Peeling RW , Boman J. , Carlone GM , Fields BS , Guarner J. , et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada) . Clin Infect Dis 2001; 33(4): 492-503.

28.

Kuo CC , Jackson LA , Campbell LA , Grayston JT Chlamydia pneumoniae (TWAR) . Clin Microbiol Rev 1995; 8(4): 451-61.

29.

Forbes RB , Wilson SV , Swingler RJ The prevalence of multiple sclerosis in Tayside , Scotland: do latitudinal gradients really exist? J Neurol 1999; 246(11): 1033-40.

30.

Poser CM , Paty DW , Scheinberg L. , McDonald WI , Davis FA , Ebers GC , et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 1983; 13(3): 227-31.

31.

Lublin FD , Reingold SC Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis . Neurology 1996; 46(4): 907-11.

32.

Casali P. , Bossus A. , Carpentier NA , Lambert PH Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled Clq binding and Raji-cell RIA tests . Clin Exp Immunol 1977; 29(2): 342-54.

33.

Tavendale R. , Parratt D. , Pringle SD , A'Brook R. , Tunstall-Pedoe H. Serological markers of Chlamydia pneumoniae infection in men and women and subsequent coronary events; the Scottish Heart Health Study Cohort . Eur Heart J 2002; 23(4): 301-7.

34.

Jones VE , Orlans E. Isolation of immune complexes and characterisation of their constituent antigens and antibodies in some human diseases: a review . J Immunol Methods 1981; 44(3): 249-70.

35.

Tsai JF , Margolis HS , Jeng JE , Ho MS , Chang WY , Hsieh MY , et al. Immunoglobulin- and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis B virus infection . Clin Immunol Immunopathol 1998; 86(3): 246-51.

36.

Tsai JF , Margolis HS , Jeng JE , Ho MS , Chang WY , Lin ZY , et al. Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection . Clin Immunol Immunopathol 1995; 75(1): 39-44.

37.

Paldanius M. , Bloigu A. , Leinonen M. , Saikku P. Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit . Clin Diagn Lab Immunol 2003; 10(1): 8-12.

38.

Holmskov U. , Haas H. , Teisner B. , Andersen O. , Jensenius JC Calcium-dependent and calcium-independent signals in the conglutinin-binding assay (KgBa) for immune complexes. Influence of anti-collagen-antibodies . J Immunol Methods 1992; 148(1-2): 225-32.

39.

Tarnacka B. , Gromadzka G. , Czlonkowska A. Increased circulating immune complexes in acute stroke: the triggering role of Chlamydia pneumoniae and cytomegalovirus . Stroke 2002; 33(4): 936-40.

40.

Glader CA , Boman J. , Saikku P. , Stenlund H. , Weinehall L. , Hallmanns G. , et al. The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae-specific IgG antibodies . Eur Heart J 2000; 21(8): 639-46.

41.

Linnanmaki E. , Leinonen M. , Mattila K. , Nieminen MS , Valtonen V. , Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease . Circulation 1993; 87(4): 1130-34.

42.

Essig A. , Simnacher U. , Susa M. , Marre R. Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation . Clin Diagn Lab Immunol 1999; 6(6): 819-25.

43.

Elkind MS , Tondella ML , Feikin DR , Fields BS , Homma S. , Di Tullio MR Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke . Stroke 2006; 37(3): 790-95.

44.

Johnsen SP , Overvad K. , Ostergaard L. , Tjonneland A. , Husted SE , Sorensen HT Chlamydia pneumoniae seropositivity and risk of ischemic stroke: a nested case-control study . Eur J Epidemiol 2005; 20(1): 59-65.

45.

Elkind MS , Lin IF , Grayston JT , Sacco RL Chlamydia pneumoniae and the risk of first ischemic stroke : the Northern Manhattan Stroke Study . Stroke 2000; 31(7): 1521-25.

46.

Socan M. , Beovic B. , Kese D. Chlamydia pneumonia and meningoencephalitis . N Engl J Med 1994; 331(6): 406 .

47.

Rodriguez A. , Rottenberg M. , Tjarnlund A. , Fernandez C. Immunoglobulin A and CD8 T-cell mucosal immune defenses protect against intranasal infection with Chlamydia pneumoniae . Scand J Immunol 2006; 63(3): 177-83.

48.

Branden E. , Koyi H. , Gnarpe J. , Gnarpe H. , Tornling G. Intermittent azithromycin treatment for respiratory symptoms in patients with chronic Chlamydia pneumoniae infection . Scand J Infect Dis 2004; 36(11-12): 811-16.

49.

Correale J. , Fiol M. , Gilmore W. The risk of relapses in multiple sclerosis during systemic infections . Neurology 2006; 67(4): 652-59.

50.

Hammerschlag MR , Apfalter P. , Boman J. , Tondella ML , Gaydos C.

The role of Chlamydia pneumoniae in multiple sclerosis: real or fictitious?

J Infect Dis 2005; 192(7): 1305-7; author reply 1307 .

51.

von HL Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae . Eur Respir J 2002 ; 19(3): 546-56.

52.

Tsumura N. , Emre U. , Roblin P. , Hammerschlag MR Effect of hydrocortisone succinate on growth of Chlamydia pneumoniae in vitro . J Clin Microbiol 1996; 34(10): 2379-81.